KR900007514B1 - 금속 방사성 핵종과 함께 킬레이트 할수 있는 염 - Google Patents
금속 방사성 핵종과 함께 킬레이트 할수 있는 염 Download PDFInfo
- Publication number
- KR900007514B1 KR900007514B1 KR1019850005137A KR850005137A KR900007514B1 KR 900007514 B1 KR900007514 B1 KR 900007514B1 KR 1019850005137 A KR1019850005137 A KR 1019850005137A KR 850005137 A KR850005137 A KR 850005137A KR 900007514 B1 KR900007514 B1 KR 900007514B1
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- group
- acid
- formula
- formulas
- Prior art date
Links
- 0 *N*C(C1(CC(CCCC2)C2N)C(C*2)C*2(C2)C2C1)=O Chemical compound *N*C(C1(CC(CCCC2)C2N)C(C*2)C*2(C2)C2C1)=O 0.000 description 5
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63231484A | 1984-07-19 | 1984-07-19 | |
| US632314 | 1984-07-19 | ||
| US632,314 | 1984-07-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR860000871A KR860000871A (ko) | 1986-02-20 |
| KR900007514B1 true KR900007514B1 (ko) | 1990-10-11 |
Family
ID=24535023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019850005137A KR900007514B1 (ko) | 1984-07-19 | 1985-07-18 | 금속 방사성 핵종과 함께 킬레이트 할수 있는 염 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0187832A1 (de) |
| JP (1) | JPS61106556A (de) |
| KR (1) | KR900007514B1 (de) |
| AU (1) | AU4635885A (de) |
| CA (1) | CA1267899A (de) |
| DK (1) | DK124786A (de) |
| ES (1) | ES8704900A1 (de) |
| FI (1) | FI861118A0 (de) |
| GR (1) | GR851792B (de) |
| NO (1) | NO860981L (de) |
| PT (1) | PT80841B (de) |
| WO (1) | WO1986000898A1 (de) |
| ZA (1) | ZA855476B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4888427A (en) * | 1987-04-07 | 1989-12-19 | University Of Florida | Amino acids containing dihydropyridine ring systems for site-specific delivery of peptides to the brain |
| US5079366A (en) * | 1987-04-07 | 1992-01-07 | University Of Florida | Quarternary pyridinium salts |
| EP0301751B1 (de) * | 1987-07-31 | 1993-03-10 | Takeda Chemical Industries, Ltd. | Pyridinium-Derivate, ihre Herstellung und Verwendung |
| DE4107570A1 (de) * | 1991-03-07 | 1992-11-19 | Diagnostikforschung Inst | Chelate, deren metallkomplexe sowie ihre verwendung in diagnostik und therapie |
| JP4677863B2 (ja) * | 2005-09-05 | 2011-04-27 | 堺化学工業株式会社 | チオール系光硬化性モノマーおよび光硬化型樹脂組成物 |
| US8701166B2 (en) | 2011-12-09 | 2014-04-15 | Blackberry Limited | Secure authentication |
| US10864279B2 (en) | 2016-12-16 | 2020-12-15 | Industrial Technology Research Institute | Linker-drug and antibody-drug conjugate (ADC) employing the same |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0224283A3 (de) * | 1982-05-18 | 1988-09-21 | University Of Florida | Gehirnspezifische Arzneimittelabgabe |
-
1985
- 1985-07-15 WO PCT/US1985/001334 patent/WO1986000898A1/en not_active Application Discontinuation
- 1985-07-15 EP EP85903633A patent/EP0187832A1/de not_active Withdrawn
- 1985-07-15 AU AU46358/85A patent/AU4635885A/en not_active Abandoned
- 1985-07-18 GR GR851792A patent/GR851792B/el unknown
- 1985-07-18 KR KR1019850005137A patent/KR900007514B1/ko not_active IP Right Cessation
- 1985-07-19 ZA ZA855476A patent/ZA855476B/xx unknown
- 1985-07-19 CA CA000487165A patent/CA1267899A/en not_active Expired - Fee Related
- 1985-07-19 JP JP60160040A patent/JPS61106556A/ja active Pending
- 1985-07-19 PT PT80841A patent/PT80841B/pt unknown
-
1986
- 1986-02-17 ES ES552072A patent/ES8704900A1/es not_active Expired
- 1986-03-14 NO NO860981A patent/NO860981L/no unknown
- 1986-03-18 DK DK124786A patent/DK124786A/da not_active Application Discontinuation
- 1986-03-18 FI FI861118A patent/FI861118A0/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ES552072A0 (es) | 1987-04-16 |
| PT80841B (en) | 1987-06-03 |
| CA1267899A (en) | 1990-04-17 |
| EP0187832A1 (de) | 1986-07-23 |
| DK124786D0 (da) | 1986-03-18 |
| GR851792B (de) | 1985-11-26 |
| NO860981L (no) | 1986-05-20 |
| ES8704900A1 (es) | 1987-04-16 |
| WO1986000898A1 (en) | 1986-02-13 |
| AU4635885A (en) | 1986-02-25 |
| FI861118A (fi) | 1986-03-18 |
| DK124786A (da) | 1986-05-20 |
| FI861118A0 (fi) | 1986-03-18 |
| JPS61106556A (ja) | 1986-05-24 |
| KR860000871A (ko) | 1986-02-20 |
| PT80841A (en) | 1985-08-01 |
| ZA855476B (en) | 1987-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4963688A (en) | Compounds for site-enhanced delivery of radionuclides and uses thereof | |
| EP0329737B1 (de) | Tri-azamakrozyklen und deren metall komplexe | |
| JPH02104588A (ja) | ５員‐又は６員‐環を有する巨大環状ポリアザ‐化合物、その製法及びこれを含有するｎｍｒ‐、ｘ線‐、放射線‐診断用及び放射能‐及び照射線‐治療用薬剤及びこの薬剤の製法 | |
| JPH06122691A (ja) | 放射性核種金属キレート | |
| CA2046654C (en) | Radiolabeled proteins for diagnostic or therapeutic use | |
| EP0499501B1 (de) | Neue makrocyclische Stickstoff-Liganden, Verfahren zu ihrer Herstellung, Metallkomplexe, diagnostische und therapeutische Zusammensetzungen | |
| US5218128A (en) | Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom | |
| US6416733B1 (en) | Radiopharmaceuticals for imaging infection and inflammation | |
| US4963682A (en) | Novel radiopharmaceuticals and chelating agents useful in their preparation | |
| US5175257A (en) | Radiolabeled proteins for diagnostic or therapeutic use | |
| KR900007514B1 (ko) | 금속 방사성 핵종과 함께 킬레이트 할수 있는 염 | |
| US5250666A (en) | Radionuclide metal chelates for the radiolabeling of proteins | |
| JPH08508261A (ja) | 二官能価キレート剤及びそれらの放射性医薬への使用 | |
| AU736481B2 (en) | Radiopharmaceuticals for imaging infection and inflammation | |
| CA2062483A1 (en) | Chelates, their metal complexes as well as their use in diagnosis and treatment | |
| US5136038A (en) | Radiopharmaceuticals and chelating agents useful in their preparation | |
| CA1266864A (en) | Radiopharmaceuticals and chelating agents useful in their preparation | |
| US5155227A (en) | Compounds for site-enhanced delivery of radionuclides | |
| US5656253A (en) | Ligands useful in radiographic imaging | |
| US20030124053A1 (en) | Radiopharmaceuticals for imaging infection and inflammation | |
| AU758249B2 (en) | Radiopharmaceuticals for imaging infection and inflamation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| G160 | Decision to publish patent application | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant | ||
| FPAY | Annual fee payment |
Payment date: 19941007 Year of fee payment: 5 |
|
| LAPS | Lapse due to unpaid annual fee |